SARILUMAB DOSE REDUCTION TO MANAGE LABORATORY ABNORMALITIES IN AN OPEN-LABEL EXTENSION STUDY IN RA PATIENTS

被引：0

作者：

Genovese, M. C. ^{[1
]}

Fay, J. ^{[2
]}

Parrino, J. ^{[2
]}

Garg, A. ^{[3
]}

Van Hoogstraten, H. ^{[3
]}

Boddy, A. ^{[3
]}

Martincova, R. ^{[4
]}

Graham, N. ^{[5
]}

Simon, J. ^{[6
]}

Burmester, G. R. ^{[7
]}

机构：

[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA

[2] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[3] Sanofi, Bridgewater, MA USA

[4] Sanofi, Prague, Czech Republic

[5] Regeneron Pharmaceut, Tarrytown, NY USA

[6] Kohler & Milstein Res, Yucatan, Mexico

[7] Charite, Berlin, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.3709

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0228

引用

页码：515 / 516

页数：2

共 50 条

[41] An open-label extension study of modafinil for the treatment of daytime sleepiness in patients with Parkinson's disease [J].

Adler, CH ;

Caviness, JN ;

Hentz, JG ;

Lind, M ;

Tiede, J .

SLEEP, 2002, 25 :A251-A252

[42] An open-label extension study to determine the safety of pirnavanserin in patients with Parkinson's disease and psychosis [J].

Mills, R. ;

Johnson, A. ;

Bahr, D. ;

Williams, H. ;

Revell, S. .

MOVEMENT DISORDERS, 2008, 23 (01) :S221-S221

[43] Results from an open-label extension study of etanercept in ankylosing spondylitis [J].

Davis, J ;

Webb, A ;

Lund, S ;

Sack, K .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (02) :302-304

[44] An open-label extension study of alendronate in elderly women with osteoporosis. [J].

Harris, ST ;

Downs, R ;

Bone, H ;

Yates, AJ ;

Lombardi, A ;

Harning, R .

JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 :S468-S468

[45] The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study [J].

Samuel Frank ;

Claudia Testa ;

Mary C. Edmondson ;

Jody Goldstein ;

Elise Kayson ;

Blair R. Leavitt ;

David Oakes ;

Christine O’Neill ;

Christina Vaughan ;

Jacquelyn Whaley ;

Nicholas Gross ;

Mark Forrest Gordon ;

Juha-Matti Savola .

CNS Drugs, 2022, 36 :1207-1216

[46] Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study [J].

Gleich, Gerald J. ;

Roufosse, Florence ;

Chupp, Geoffrey ;

Faguer, Stanislas ;

Walz, Bastian ;

Reiter, Andreas ;

Yancey, Steven W. ;

Bentley, Jane H. ;

Steinfeld, Jonathan .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12) :4431-+

[47] An Open-Label Extension Study of Alendronate Treatment in Elderly Women with Osteoporosis [J].

R. W. Downs, Jr. ;

H. G. Bone ;

H. McIlwain ;

M. Z. Baker ;

A. J. Yates ;

A. Lombardi ;

D. Krupa ;

R. Harning .

Calcified Tissue International, 1999, 64 :463-469

[48] The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study [J].

Frank, Samuel ;

Testa, Claudia ;

Edmondson, Mary C. ;

Goldstein, Jody ;

Kayson, Elise ;

Leavitt, Blair R. ;

Oakes, David ;

O'Neill, Christine ;

Vaughan, Christina ;

Whaley, Jacquelyn ;

Gross, Nicholas ;

Gordon, Mark Forrest ;

Savola, Juha-Matti .

CNS DRUGS, 2022, 36 (11) :1207-1216

[49] Results of switching to laquinimod in the open-label extension phase of the BRAVO study [J].

Vollmer, T. ;

Sorensen, P. S. ;

Selmaj, K. ;

Zipp, F. ;

Havrdova, E. ;

Cohen, J. ;

Sidi, Y. ;

Gorfine, T. ;

Arnold, D. .

MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) :489-489

[50] An open-label extension study of alendronate treatment in elderly women with osteoporosis [J].

Downs, RW ;

Bone, HG ;

McIlwain, H ;

Baker, MZ ;

Yates, AJ ;

Lombardi, A ;

Krupa, D ;

Harning, R .

CALCIFIED TISSUE INTERNATIONAL, 1999, 64 (06) :463-469

← 1 2 3 4 5 →